Mexico · Delayed Price · Currency is MXN Vitro Statistics
Total Valuation
Vitro has a market cap or net worth of MXN 1.75 billion. The enterprise value is 3.55 billion.
| Market Cap | 1.75B |
| Enterprise Value | 3.55B |
Important Dates
The next estimated earnings date is Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vitro has 470.03 million shares outstanding. The number of shares has decreased by -0.83% in one year.
| Current Share Class | 470.03M |
| Shares Outstanding | 470.03M |
| Shares Change (YoY) | -0.83% |
| Shares Change (QoQ) | +5.09% |
| Owned by Insiders (%) | 72.59% |
| Owned by Institutions (%) | 0.36% |
| Float | 41.39M |
Valuation Ratios
The trailing PE ratio is 0.74.
| PE Ratio | 0.74 |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| PB Ratio | 2.04 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | 1.04 |
| P/OCF Ratio | 0.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.10, with an EV/FCF ratio of 2.11.
| EV / Earnings | 1.25 |
| EV / Sales | 0.70 |
| EV / EBITDA | 19.10 |
| EV / EBIT | n/a |
| EV / FCF | 2.11 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 2.30.
| Current Ratio | 1.32 |
| Quick Ratio | 1.30 |
| Debt / Equity | 2.30 |
| Debt / EBITDA | 8.92 |
| Debt / FCF | 1.17 |
| Interest Coverage | -0.50 |
Financial Efficiency
Return on equity (ROE) is 35.77% and return on invested capital (ROIC) is -1.78%.
| Return on Equity (ROE) | 35.77% |
| Return on Assets (ROA) | -0.50% |
| Return on Invested Capital (ROIC) | -1.78% |
| Return on Capital Employed (ROCE) | -1.43% |
| Weighted Average Cost of Capital (WACC) | 11.72% |
| Revenue Per Employee | 10.78M |
| Profits Per Employee | 6.05M |
| Employee Count | 468 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 22.94 |
Taxes
In the past 12 months, Vitro has paid 74.28 million in taxes.
| Income Tax | 74.28M |
| Effective Tax Rate | 3.06% |
Stock Price Statistics
The stock price has decreased by -32.36% in the last 52 weeks. The beta is 0.31, so Vitro's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -32.36% |
| 50-Day Moving Average | 4.83 |
| 200-Day Moving Average | 5.51 |
| Relative Strength Index (RSI) | 32.27 |
| Average Volume (20 Days) | 2,508 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitro had revenue of MXN 5.05 billion and earned 2.83 billion in profits. Earnings per share was 6.02.
| Revenue | 5.05B |
| Gross Profit | 1.92B |
| Operating Income | -169.37M |
| Pretax Income | 2.43B |
| Net Income | 2.83B |
| EBITDA | 196.70M |
| EBIT | -169.37M |
| Earnings Per Share (EPS) | 6.02 |
Balance Sheet
The company has 159.83 million in cash and 1.96 billion in debt, with a net cash position of -1.80 billion or -3.84 per share.
| Cash & Cash Equivalents | 159.83M |
| Total Debt | 1.96B |
| Net Cash | -1.80B |
| Net Cash Per Share | -3.84 |
| Equity (Book Value) | 855.32M |
| Book Value Per Share | 1.82 |
| Working Capital | 1.72B |
Cash Flow
In the last 12 months, operating cash flow was 2.06 billion and capital expenditures -380.39 million, giving a free cash flow of 1.68 billion.
| Operating Cash Flow | 2.06B |
| Capital Expenditures | -380.39M |
| Depreciation & Amortization | 360.14M |
| Net Borrowing | -2.83B |
| Free Cash Flow | 1.68B |
| FCF Per Share | 3.57 |
Margins
Gross margin is 37.99%, with operating and profit margins of -3.36% and 56.14%.
| Gross Margin | 37.99% |
| Operating Margin | -3.36% |
| Pretax Margin | 48.12% |
| Profit Margin | 56.14% |
| EBITDA Margin | 3.90% |
| EBIT Margin | -3.36% |
| FCF Margin | 33.84% |
Dividends & Yields
Vitro does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.83% |
| Shareholder Yield | 0.83% |
| Earnings Yield | 162.04% |
| FCF Yield | 96.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 8, 1995. It was a forward split with a ratio of 1.2.
| Last Split Date | May 8, 1995 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Vitro has an Altman Z-Score of 0.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.54 |
| Piotroski F-Score | 4 |